Home LiteratureArticle Details
PMID: 1525626 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome.

British journal of rheumatology ·Vol. 31 ·No. 9 ·1992-09-00 ·Pages 609-13

Langevitz P, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P

Abstract

HLA antigen distribution was studied in 126 patients with systemic sclerosis (SSc) followed prospectively and compared to that of 325 healthy controls. The frequencies of HLA antigens DR3, DR5 and DRw52 were increased in patients with diffuse skin involvement (P = 0.02, 0.05, 0.03). The presence of DRw52 (relative risk [RR] much much greater than 1) and DRw6 (RR = 54.5) was associated with significantly increased risks of a fatal disease outcome with pulmonary hypertension (PHT). In the absence of PHT, DRw252 was inversely associated with the risk of death. These findings indicate an adverse prognosis in SSc when PHT is present in association with DRw52.

MeSH Terms
HLA Antigens/analysis,classification,genetics Humans Hypertension, Pulmonary/complications,mortality Prospective Studies Risk Factors Scleroderma, Localized/complications,immunology Scleroderma, Systemic/complications,immunology,mortality Survival Analysis Time Factors
Chemicals
HLA Antigens
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Langevitz P
University of Toronto Rheumatic Disease Unit, Wellesley Hospital, Ontario, Canada.
Buskila D
Gladman D D
Darlington G A
Farewell V T
Lee P
Article Info
Journal
British journal of rheumatology
Abbr.
Br J Rheumatol
ISSN
0263-7103
Published
1992-09-00
Pages
609-13
Language
English
Region
England
NLM ID
8302415
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com